# Beike Biotech > Shenzhen Beike Biotechnology Co., Ltd. is a biotechnology company founded in 2005 with cell-research, biobanking, controlled cell-preparation and translational-research capabilities in China. This is its English-language corporate website. The Chinese-language sister site is at https://beike.cc — each article here links to its Chinese original via a zh-CN alternate. Historical articles are translated archive material and may not reflect current scientific, commercial or regulatory status. The website does not provide medical advice. ## Key pages - [About Beike](https://beikebiotech.com/about): Company profile, history, milestones and qualifications. - [R&D Platforms](https://beikebiotech.com/rd-platform): Research platforms, expert network and partner institutions. - [Quality Systems](https://beikebiotech.com/quality): Quality management, traceability, testing and accreditation context. - [Standards & Accreditation](https://beikebiotech.com/standardization): Beike's work on national, group and industry standards for cell-related activities. - [Products & Services](https://beikebiotech.com/products): Overview of the cell storage and preparation services. - [Stem Cell Storage](https://beikebiotech.com/stem-cell-storage): Umbilical cord, cord blood and other stem cell storage services. - [Immune Cell Storage](https://beikebiotech.com/products/immune-cell-storage): Immune cell collection and cryogenic storage. - [Cell Preparation](https://beikebiotech.com/products/cell-preparation): Controlled cell preparation and process-development capabilities. - [Partnerships](https://beikebiotech.com/partnerships): Research, hospital and commercial collaboration routes. - [Video Gallery](https://beikebiotech.com/about/videos): Company and interview videos. - [News](https://beikebiotech.com/news): Company and industry news archive. - [Contact](https://beikebiotech.com/contact): Enquiry form, headquarters and regional offices. - [Medical Information Notice](https://beikebiotech.com/medical-information): Context and limitations for medical and research information. - [Privacy Notice](https://beikebiotech.com/privacy): How corporate enquiries and submitted information are handled. ## Company news Index: https://beikebiotech.com/news/company - [Beike Biotech's 'Human Umbilical Cord Mesenchymal Stem Cell Therapy Technology for Type 2 Diabetes' officially approved at Boao Lecheng](https://beikebiotech.com/article/beike-biotechs-human-umbilical-cord-mesenchymal-stem-cell-therapy): 2026-01-20 — On December 30, 2025, the Hainan Boao Lecheng Medical and Drug Administration officially approved Ciming Boao International Hospital to carry out the… - [Important notice on guarding against the unauthorized use of the 'Beike Biotech' name in business activities](https://beikebiotech.com/article/important-notice-on-guarding-against-the-unauthorized-use-of-the): 2025-12-12 — Shenzhen Beike Biotechnology Co., Ltd. issues a formal notice on the prevention of fraudulent use of the 'Beike Biotech' name in commercial activities,… - [Process research from Beike Biotech's Preparation Center published in the renowned international journal Stem Cell Research & Therapy](https://beikebiotech.com/article/process-research-from-beike-biotechs-preparation-center-published-in): 2024-05-08 — The 2024 latest process research from Beike Biotech's Preparation Center has been published in the renowned international journal Stem Cell Research &… - [Major news! Beike Biotech's in-house developed first domestic stem cell new drug for systemic lupus erythematosus approved for clinical trials](https://beikebiotech.com/article/beike-biotechs-in-house-developed-first-domestic-stem-cell-new-drug): 2024-04-28 — On April 28, 2024, Beike Biotech's in-house developed innovative cell drug 'Human Umbilical Cord Mesenchymal Stem Cell Injection' for the treatment of… - [Beike Biotech invited to attend the SUSTech Global Excellence Innovation Talent Summer School information session, jointly building the future of biotechnology](https://beikebiotech.com/article/beike-biotech-invited-to-attend-the-sustech-global-excellence): 2024-04-24 — On April 11, 2024, the Global Excellence Innovation Talent Summer School information session, co-hosted by Southern University of Science and Technology… - [Chongqing Medicine and Beike Biotech jointly hold 'Symposium on Clinical Application and Translational Development of New Stem Cell Technologies'](https://beikebiotech.com/article/chongqing-medicine-and-beike-biotech-jointly-hold-symposium-on): 2024-04-17 — On the afternoon of April 11, the 'Symposium on Clinical Application and Translational Development of New Stem Cell Technologies', co-hosted by the… - [New standardization breakthrough! Beike Biotech-co-authored group standard 'General Requirements for Human-Derived Cell Storage Services' released!](https://beikebiotech.com/article/new-standardization-breakthrough-beike-biotech-co-authored-group): 2024-04-15 — Beike Biotech has once again demonstrated its active contribution to industry standardization. - [The 2024 latest research from Beike Biotech's empowered stem cell technology platform published in the leading international journal Cell & Bioscience!](https://beikebiotech.com/article/the-2024-latest-research-from-beike-biotechs-empowered-stem-cell): 2024-04-09 — The 2024 latest research from Beike Biotech's empowered stem cell technology platform has been published in the leading international journal Cell &… - [Top international publisher Elsevier congratulates Dr. Liao Yan on her research's positive contribution to the UN Sustainable Development Goals!](https://beikebiotech.com/article/top-international-publisher-elsevier-congratulates-dr-liao-yan-on-her): 2024-04-07 — Dr. Liao Yan of Beike Biotech's R&D Center recently received a letter of congratulations from the top international publisher Elsevier. - [Deepening industrial chain layout! Beike Biotech and Sino Biological reach a strategic partnership](https://beikebiotech.com/article/deepening-industrial-chain-layout-beike-biotech-and-sino-biological): 2024-03-29 — On March 28, 2024, Shenzhen Beike Biotechnology Co., Ltd. (hereinafter 'Beike Biotech') and Beijing Sino Biological Inc. - [Innovation leads the way! Beike Biotech sweeps four honors including the 2023 Greater Bay Area Enterprise Innovation List](https://beikebiotech.com/article/beike-biotech-sweeps-four-honors-including-the-2023-greater-bay-area): 2024-03-15 — On the afternoon of March 14, themed 'Gathering industry-academia-research innovation momentum to build a high-quality development system', the 4th… - [Kudos! Beike Biotech once again named one of the 'Top 100 Shenzhen Brands'!](https://beikebiotech.com/article/beike-biotech-once-again-named-one-of-the-top-100-shenzhen-brands): 2024-02-29 — Good news at the start of the new year! On February 27, 2024, the Shenzhen Quality Strong City Promotion Association released the list of the 3rd 'Top 100… ## Industry news Index: https://beikebiotech.com/news/industry - [CDE issues Guiding Principles: organoids may serve as efficacy and safety evaluation models for non-clinical research of human-derived stem cell products](https://beikebiotech.com/article/cde-issues-guiding-principles-organoids-may-serve-as-efficacy-and): 2023-10-10 — In recent years, with the development of stem cell technology, deepened understanding, and accumulated experience, stem cell therapy has gradually become… - [Major News! Organoids Listed for the First Time in CDE Guidelines for Gene Therapy and Cell Therapy](https://beikebiotech.com/article/organoids-listed-for-the-first-time-in-cde-guidelines-for-gene): 2021-12-06 — Recently, the Center for Drug Evaluation (CDE) of the National Medical Products Administration consecutively issued three guidelines related to gene… - [Shenzhen Issues "1+3" Documents on Cluster Development of the Biopharmaceutical Industry; Up to RMB 300 Million Funding for Key Cell-Drug Technology!](https://beikebiotech.com/article/shenzhen-issues-1-3-documents-on-cluster-development-of-the): 2021-11-27 — Recently, in order to implement the policy spirit of the "Opinions of the CPC Central Committee and the State Council on Supporting Shenzhen in Building a… - [Latest news! The first stem cell clinical research project in China's plastic surgery specialty has been filed with the National Health Commission!](https://beikebiotech.com/article/the-first-stem-cell-clinical-research-project-in-chinas-plastic): 2021-11-16 — Stem cell research in China is accelerating, with another stem cell clinical research project filed with the National Health Commission. - [Good news! Another stem cell clinical research project has been approved by the National Health Commission](https://beikebiotech.com/article/another-stem-cell-clinical-research-project-has-been-approved-by-the): 2021-11-10 — 'Regenerative medicine technology', represented by stem cell technology, is the 'third medical revolution' following pharmaceutical and surgical treatment. - [Policy issued! Tianjin Free Trade Zone's pilot for clinical translational application of gene and cell therapy approved!](https://beikebiotech.com/article/tianjin-free-trade-zones-pilot-for-clinical-translational-application): 2021-11-04 — To pilot national systems on a broader scale and with more coordinated resources, fully leverage innovation platforms, and empower industrial innovation… - [Multiple stem cell research achievements honored at the 2020 National Science and Technology Awards!](https://beikebiotech.com/article/multiple-stem-cell-research-achievements-honored-at-the-2020-national): 2021-11-04 — On November 3, at the 2020 National Science and Technology Awards Conference held in Beijing, multiple research achievements in the cell field received… - [Guangdong releases the application guidelines for the 'Precision Medicine and Stem Cells' key special program, with a dedicated direction for product development of stem cell therapies for major refractory diseases!](https://beikebiotech.com/article/guangdong-releases-the-application-guidelines-for-the-precision): 2021-10-13 — The Guangdong Provincial Department of Science and Technology recently officially released the 2021–2022 Application Guidelines for the 'Precision… - [The Politburo of the CPC Central Committee held a group study session on strengthening China's biosecurity development](https://beikebiotech.com/article/the-politburo-of-the-cpc-central-committee-held-a-group-study-session): 2021-10-08 — On the afternoon of September 29, the Politburo of the CPC Central Committee held its 33rd group study session on strengthening China's biosecurity… - [Shenzhen legislates for the cell and gene industry: the entire cell and gene industrial chain to be brought within the scope of promotion!](https://beikebiotech.com/article/shenzhen-legislates-for-the-cell-and-gene-industry-the-entire-cell): 2021-09-02 — Another important Shenzhen legislation in an emerging field — the Shenzhen Special Economic Zone Regulations on Promoting the Cell and Gene Industry… - [Shenzhen to legislate on the management of cell and gene therapy!](https://beikebiotech.com/article/shenzhen-to-legislate-on-the-management-of-cell-and-gene-therapy): 2020-12-12 — An industry boost! According to Shenzhen TV's Shenzhen News: in order to implement the requirements of the Implementation Plan for the Comprehensive… - [Five Guangdong departments jointly issue document: support for the development of strategic pillar industries in biopharmaceuticals and health, including cell therapy!](https://beikebiotech.com/article/five-guangdong-departments-jointly-issue-document-support-for-the): 2020-10-27 — Recently, five departments — the Department of Science and Technology, the Development and Reform Commission, the Department of Industry and Information… ## Optional - [Search](https://beikebiotech.com/search): Full-text search across the site. - [XML sitemap](https://beikebiotech.com/sitemap-index.xml): Complete machine-readable URL inventory.